ENSC News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$10.1M

Volume

488.23K

Next Earnings

November 13th

Chart Financials Earnings News About Insider Filings

Tiny Pain-Focused Biotech Ensysce Biosciences Surges Amid Strategic ReviewEnsysce Biosciences (NASDAQ: ENSC) shares surged 58.66% to $0.63 on Friday after the company announced a strategic review of alternatives aimed at enhancing shareholder value. The Board is exploring partnerships, licensing arrangements, or asset sales to advance its proprietary TAAP and MPAR platforms for safer opioid medicines.Benzinga · Feb 27, 2026

Follow-Through Leaders: Production Ramps, AI Alliances, Balance Sheet StrengthSeveral companies are transitioning from strategic announcements to operational execution. Kraig Biocraft Laboratories has begun production of recombinant spider silk and received National Geographic cover feature. Rackspace and Palantir announced a strategic partnership to deploy enterprise AI in production environments. Ensysce Biosciences initiated a formal strategic review to explore partnerships and enhance shareholder value.GlobeNewswire Inc. · Feb 27, 2026

Chronic and Acute Pain Clinical Trial Pipeline Analysis: 150+ Key Companies Shaping the Future of Chronic and Acute Pain Therapeutics | DelveInsightDelveInsight released a comprehensive analysis of the chronic and acute pain clinical trial pipeline, identifying 150+ active companies developing 200+ pipeline drugs across various clinical stages. The report highlights a shift toward non-opioid, targeted, and multimodal approaches due to growing concerns about opioid dependence. Recent developments include FDA orphan drug designation for Adolore BioTherapeutics' gene therapy, positive Phase IIb results for Dogwood Therapeutics' Halneuron, and Phase III publication of Vertanical's VER-01 for chronic low back pain.GlobeNewswire Inc. · Jan 28, 2026

Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC)Ensysce Biosciences advanced multiple clinical initiatives in Q2 2025, including launching a Phase 3 trial for PF614, completing enrollment in an overdose prevention study, and receiving a patent notice for its OUD program.GlobeNewswire Inc. · Aug 15, 2025

Ensysce Biosciences Narrows Loss in Q2Ensysce Biosciences reported Q2 2025 results, advancing its PF614 opioid program to Phase 3 and achieving milestones in overdose-protection studies. The company reported a narrower GAAP loss of $(0.79) per share, with revenue primarily from federal grants.The Motley Fool · Aug 13, 2025

Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionShares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on revenue of $6.17 billion. AMD shares dipped 3.8% to $165.49 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 204% to $0.6049. Connexa said it has regained compliance with Nasdaq minimum shareholder equity rule. Minim, Inc. (NASDAQ: MINM) shares climbed 76.4% to $4.48. David E. Lazar disclosed a 51% active stake in Minim Inc. Powell Industries, Inc. (NASDAQ: POWL) shares gained 49% to $121.89 after the company reported better-than-expected first-quarter financial results and raised its quarterly dividend. Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) climbed 46.5% to $0.1180 after falling around 7% on Tuesday. Ashford Hospitality Trust, Inc. (NYSE: AHT) jumped 32% to $1.77. 2seventy bio, Inc. (NASDAQ: TSVT) rose 31.6% to $5.28. 2seventy Bio said it will focus exclusively on commercialization and development of Abecma and sell its R&D pipeline to Regeneron. Leerink Partners analyst Daina Graybosch upgraded 2seventy bio from Market Perform to Outperform and raised the price target from $5 to $18. Trinity Biotech plc (NASDAQ: TRIB) gained 29.5% to $0.5638. Trinity Biotech announced acquisition of the CGM assets of Waveform Technologies, Inc. Kuke Music Holding Limited (NYSE: KUKE) rose 23.7% to $1.25. Vaxart, Inc. (NASDAQ: VXRT) jumped 20.9% to $1.1850. B. Riley Securities analyst Mayank Mamtani upgraded Vaxart from Neutral to Buy and announced a $2 price target. Envirotech Vehicles, Inc. (NASDAQ: EVTV) gained 20.6% to $1.75. Ensysce Biosciences, Inc. (NASDAQ: ENSC) gained 19.6% to ...Benzinga · Jan 31, 2024

Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionShares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares tumbled 17.2% to $2.9387 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Getaround, Inc. (NYSE: GETR) shares jumped 151.3% to $0.4618 after the company announced a new debt facility with Mudrick Capital Management for up to $20 million. Evaxion Biotech A/S (NASDAQ: EVAX) gained 94.4% to $9.70 after a 13G filing showed Merck & Co reported an 11.4% stake in the company as of Dec. 21, 2023. SciSparc Ltd. (NASDAQ: SPRC) shares gained 61.3% to $5.58 after the company revealed $20 million standby equity purchase agreement. Kura Oncology, Inc. (NASDAQ: KURA) rose 41.3% to $18.99. Kura Oncology announced oversubscribed $150 million private placement. Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares jumped 32.2% to $1.8372. Ensysce Biosciences shares gained 22% on Tuesday after the company announced FDA Breakthrough Therapy Designation for PF614-MPAR. RedHill Biopharma Ltd. (NASDAQ: RDHL) climbed 25.5% to $1.1197. Redhill Biopharma was granted U.S. Patent #11878011 for "Method for Eradicating Helicobacter Pylori Infection in Patients Regardless of Body Mass Index." Purple Innovation, Inc. (NASDAQ: PRPL) gained 24% to $1.02 after the company announced it strengthened its balance sheet, creating greater financial flexibility to execute its ...Benzinga · Jan 24, 2024

Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving PremarketShares of Netflix, Inc. (NASDAQ: NFLX) shares rose sharply in today’s pre-market trading as the company reported better-than-expected sales for its fourth quarter. Netflix reported fourth-quarter revenue of $8.83 billion, which was up 12.5% year-over-year. The total came in ahead of a Street consensus estimate of $8.72 billion. The company reported fourth-quarter earnings per share of $2.11, which missed a Street consensus estimate of $2.21. The company, meanwhile, added 13.12 million net paid subscribers in the fourth quarter. Netflix shares jumped 10.2% to $542.48 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Getaround, Inc. (NYSE: GETR) gained 50.7% to $0.2771 in pre-market trading after the company announced a new debt facility with Mudrick Capital Management for up to $20 million. Evaxion Biotech A/S (NASDAQ: EVAX) gained 43.2% to $7.15 in pre-market trading after a 13G filing showed Merck & Co reported an 11.4% stake in the company as of December 21, 2023. VS MEDIA Holdings Limited (NASDAQ: VSME) shares jumped 31.7% to $0.4318 in ...Benzinga · Jan 24, 2024

Crude Oil Down 1%; Lockheed Martin Earnings Top ViewsU.S. stocks traded mixed toward the end trading, with the Dow Jones index falling around 100 points on Tuesday. The Dow traded down 0.26% to 37,903.57 while the NASDAQ rose 0.25% to 15,399.02. The S&P 500 also rose, gaining, 0.18% to 4,859.01. Check This Out: How To Earn $500 A Month From Nvidia Stock Leading and Lagging Sectors Consumer staples shares rose by 0.8% on Tuesday. In trading on Tuesday, real estate shares fell by 0.8%. Top Headline Lockheed Martin Corp (NYSE: LMT) company posted upbeat earnings for its fourth quarter. Lockheed Martin posted quarterly sales of $18.87 billion, beating the consensus of $17.97 billion. EPS in the fourth quarter was $7.58, up from $7.40 per share last year, versus the consensus of $7.28. Equities Trading UP FaZe Holdings Inc.. (NASDAQ: FAZE) shares shot up 116% to $0.3340 after the company announced Rollbit will sponsor its Counter-Strike team. Shares of Ensysce Biosciences, Inc. (NASDAQ: ENSC) got a boost, surging ...Benzinga · Jan 23, 2024

Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionShares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-quarter EPS, but issued FY24 EPS guidance below estimates. Adjusted EPS was $2.42 compared to $2.18 in prior-year quarter, beating the consensus of $2.31. For FY24, MMM sees adjusted sales growth of 0.25% to 2.25% and adjusted EPS of $9.35 – $9.75 vs. $9.82 estimate. 3M shares dipped 12.5% to $94.54 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers FaZe Holdings Inc.. (NASDAQ: FAZE) shares climbed 63.6% to $0.2528. FaZe and Rollbit announced a new multi-million dollar esports sponsorship deal. Rail Vision Ltd. (NASDAQ: RVSN) jumped 57.4% to $3.5420. Rail Vision recently announced its Main Line system has successfully obtained formal certifications for critical European Union railway standards. Nuvve Holding Corp. (NASDAQ: NVVE) shares surged 44.6% to $4.31. Nuvve won a $16 million project for Fresno Economic Opportunities Commission's 50-shuttle fleet. Ensysce Biosciences, Inc. (NASDAQ: ENSC) gained 29% to $1.4701. Ensysce Biosciences said that the FDA has granted Breakthrough Therapy Designation for PF614-MPAR. Bit Brother Limited (NASDAQ: BETS) surged 26% to $3.97 after the company requested immediate withdrawal of its Registration Statement on Form F-3 filed with the SEC on Jan. 16, 2024. Gamer Pakistan Inc. (NASDAQ: GPAK) shares climbed 21.8% to $0.3180 after falling more than 9% on Monday. Sensus Healthcare, Inc. (NASDAQ: SRTS) gained 21.4% to $3.23. Sensus Healthcare announced preliminary fourth-quarter revenue of $12 million and 2023 revenue exceeding $23 million. Catheter Precision, Inc. (NYSE: VTAK) rose 20.8% to $0.58. Catheter Precision Director, Executive Chairman and CEO David A Jenkins acquired a total of 16,940 shares at an average price of $0.42. Solid Power, Inc. (NASDAQ: SLDP) rose 20.5% to $1.41. Solid Power announced a $50 million share repurchase authorization. Unicycive Therapeutics, Inc. (NASDAQ: UNCY) gained 20.3% to $0.9999. Unicycive Therapeutics ...Benzinga · Jan 23, 2024

ENSCEnsysce Biosciences, Inc. Common Stock

ENSC

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any ENSC yet.

Related Tickers

Earnings

Mkt Cap

$10.4M

Volume

488.23K

Next Earnings

November 13th